The Departments of Dermatology, Biochemistry and Molecular Pharmacology, and the NYU Cancer Institute, NYU Langone Medical Center, New York, NY, USA.
Curr Genomics. 2012 Aug;13(5):363-8. doi: 10.2174/138920212801619241.
Recent years witnessed the birth of bioinformatics technologies, which greatly advanced biological research. These 'omics' technologies address comprehensively the entire genome, transcriptome, proteome, microbiome etc. A large impetus in development of bioinformatics was the introduction of DNA microarrays for transcriptional profiling. Because of its accessibility, skin was among the first organs analyzed using DNA microarrays, and dermatology among the first medical disciplines to embrace the approach. Here, DNA microarray methodologies and their application in dermatology and skin biology are reviewed. The most studied disease has been, unsurprisingly, melanoma; markers of melanoma progression, metastatic potential and even melanoma markers in blood have been detected. The basal and squamous cell carcinomas have also been intensely studied. Psoriasis has been comprehensively explored using DNA microarrays, transcriptional changes correlated with genomic markers and several signaling pathways important in psoriasis have been identified. Atopic dermatitis, wound healing, keloids etc. have been analyzed using microarrays. Noninvasive skin sampling for microarray studies has been developed. Simultaneously, epidermal keratinocytes have been the subject of many skin biology studies because they respond to a rich variety of inflammatory and immunomodulating cytokines, hormones, vitamins, UV light, toxins and physical injury. The transcriptional changes occurring during epidermal differentiation and cornification have been identified and characterized. Recent studies identified the genes specifically expressed in human epidermal stem cells. As dermatology advances toward personalized medicine, microarrays and related 'omics' techniques will be directly applicable to the personalized dermatology practice of the future.
近年来,生物信息学技术应运而生,极大地推动了生物学研究的发展。这些“组学”技术全面涵盖了整个基因组、转录组、蛋白质组、微生物组等。生物信息学发展的一个主要动力是 DNA 微阵列在转录谱分析中的引入。由于其易于获取,皮肤是最早使用 DNA 微阵列进行分析的器官之一,皮肤科是最早采用这种方法的医学学科之一。本文综述了 DNA 微阵列方法及其在皮肤科和皮肤生物学中的应用。研究最多的疾病是黑色素瘤,这并不奇怪;已经检测到黑色素瘤进展、转移潜力甚至血液中的黑色素瘤标志物。基底细胞癌和鳞状细胞癌也受到了深入研究。银屑病也使用 DNA 微阵列进行了全面研究,确定了与基因组标记相关的转录变化,以及在银屑病中起重要作用的几个信号通路。特应性皮炎、伤口愈合、瘢痕疙瘩等也使用微阵列进行了分析。已经开发出用于微阵列研究的非侵入性皮肤采样方法。同时,表皮角质形成细胞是许多皮肤生物学研究的对象,因为它们对各种炎症和免疫调节细胞因子、激素、维生素、紫外线、毒素和物理损伤有反应。已经确定并描述了表皮分化和角化过程中发生的转录变化。最近的研究确定了人类表皮干细胞中特异性表达的基因。随着皮肤科向个性化医学的发展,微阵列和相关的“组学”技术将直接适用于未来的个性化皮肤科实践。